The AAPP Foundation continues to proudly support the AAPP Outcomes Initiative with a second $250,000 research grant. This 2025 grant has been awarded to study the impact of care by psychiatric pharmacists on the treatment of depression. The project, “Alternate Prescriber Type - Depression Management (Trial APT-DM): Impact of Psychiatric Pharmacist on Major Depressive Disorder in Primary Care,” will be led by Co-Principal Investigators, Dr. Nathaniel Rickles (UConn School of Pharmacy), Dr.
Efforts to reduce barriers to methadone initiation via partnerships between mobile health programs, SSPs, and OTPs can be a tool in combating the overdose crisis.
In this cohort study, based on data from US healthcare claims databases, initiating citalopram, escitalopram, fluoxetine, or paroxetine while on hydrocodone was associated with an increased risk of opioid overdose compared with sertraline.
Given the high level of stigma and shame experienced by PWUDs, the lowest barrier HRVM access models should be adopted to promote equitable access to harm reduction and basic needs supplies.
Integrating methadone treatment into primary care settings improves adherence to guideline-concordant health care without compromising methadone retention and treatment quality.
Medication adherence may prevent overdose, ED use, and hospitalization. Strategies to increase treatment duration/adherence likely avert harm.
Total morbidity-related productivity losses attributable to substance use disorder in the U.S. are substantial, amounting to $92.65 billion in 2023.
No summary available
No summary available
No summary available
Psych pharmacists explain meds. Patients take control. #choosepsychpharmacy #pharmd #psychpharm #AAPP
Struggling ➝ stable ➝ thriving. Psych pharmacists make it happen. #choosepsychpharmacy #pharmd #psychpharm #AAPP
Every brain = different. Psych pharmacists customize the treatment plan. #choosepsychpharmacy #pharmd #psychpharm #AAPP
Science that helps people. That’s the job of a psych pharmacist. #choosepsychpharmacy #pharmd #psychpharm #AAPP
No summary available
Check out AAPP's newest policy brief stating our support for the evidence-based treatment of autism spectrum disorder based on an accurate assessment of the available data.
Check out AAPP's newest policy brief stating our support for the evidence-based treatment of autism spectrum disorder based on an accurate assessment of the available data.
No summary available
Have you considered starting a new PGY-2 Psychiatric Pharmacy residency program at your facility but have no idea where to begin? Here are some considerations and starting points to help the process feel less overwhelming.
Peer reviewing is not just for senior clinicians and academics. When you peer review, you are participating in an important gatekeeping role...and the endeavor is a worthy one.
AAPP issues policy recommendations supporting access to psychiatric pharmacy care for foster care youth. AAPP urges each state to include BCPP(s) on the foster care team and state DUR committees and urges CMS to provide best practice guidance to states.
No summary available
AAPP has recently released a summary of recommended policy actions to support access to trauma-informed care for all youth in foster care and access to psychotropics for those with co-occurring mental health conditions. Additionally, the recommendations call for updates to foster care psychotropic prescribing regulations. Policy recommendations urge that each state include BCPP(s) on the foster care team as well as on any state DUR committee.
AAPP joined with fellow members of the Pharmacy-Based Vaccine Access Work Group to support the importance of vaccines and the role of the pharmacist.
Findings suggest that patient characteristics associated with buprenorphine initiation may differ by health care setting. However, retention among subgroups of patients appears similar across settings.